The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
Sign Up to like & getrecommendations! Published in 2024 at "Scientific Reports"
DOI: 10.1038/s41598-024-75293-5
Abstract: The studies evaluating the impact of Her2 levels in neoadjuvant setting have conflicting data. The aim of the study was to evaluate the prognostic impact of Her2 status in early triple negative breast cancer(TNBC). In… read more here.
Keywords: oncology; impact her2; her2; study ... See more keywords
Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14102509
Abstract: Simple Summary HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer (BC) is an emerging subtype of BC with promising results with antibody drug conjugate (ADC) in the metastatic setting. In the early setting, few data… read more here.
Keywords: neoadjuvant chemotherapy; her2 status; her2; status ... See more keywords